Scientists at the University of California, Irvine, have identified a previously unknown mechanism in the small intestine that may explain why fructose, when eaten in excess, helps drive weight gain, not just through extra calories but by changing how the gut absorbs fat.
The study, titled "Intestinal fructose catabolism promotes obesity and insulin resistance via ileal lacteal remodeling," was published on August 28, 2026, in the journal Science Advances. It points to a link between fructose, gut bacteria and fat absorption that had gone largely unnoticed until now.
Fructose has long carried a poor reputation in nutrition circles. High-fructose corn syrup is one of the added sugars widely used in soft drinks and processed foods, and high intake of free sugars is linked to weight gain. The World Health Organization recommends keeping free sugars below 10% of total daily energy intake, and says cutting further to 5% or less may bring additional health benefits.
How the researchers tested it
The team focused on the small intestine, one of the first sites where dietary fructose is broken down. They zeroed in on ketohexokinase-C (KHK-C), a highly active form of the enzyme that carries out the first step of fructose metabolism.
Earlier research had shown the small intestine can process much of the fructose a person eats before it reaches the liver, though this capacity can be overwhelmed at high doses, sending more fructose on to the liver and the colon's microbiome. Other work had suggested intestinal fructose metabolism can act as a kind of shield for the liver by limiting how much fructose reaches it.
To see what happens when that enzyme is switched off specifically in the gut, the researchers used genetically modified mice lacking KHK-C in their intestinal cells. For up to 12 weeks, the animals drank water with a high concentration of high-fructose corn syrup, alongside comparison groups of normal mice and mice given plain water. The scientists tracked body weight, fat mass, calorie intake and markers of glucose metabolism.
Mice gained less weight despite eating similar calories
Mice lacking intestinal KHK-C gained significantly less weight and stored less fat than normal mice, even though they consumed a similar number of calories overall. They also showed better glucose tolerance and lower fasting insulin. Something besides calorie intake was clearly at work: the animals were taking in energy from food but processing dietary fat differently.
The role of lacteal vessels
To find out why, the researchers gave the mice a dose of soybean oil and measured how much fat entered the bloodstream versus how much was excreted. The trail led to the lacteals, microscopic lymphatic vessels inside the finger-like projections of the intestinal lining that carry absorbed fat away from the gut.
In mice where normal intestinal fructose breakdown was blocked, the lacteals in the ileum were shorter. A smaller absorptive surface meant less fat could pass efficiently into the body, and more of it was excreted instead. The study links suppressed intestinal fructose metabolism directly to reduced fat absorption, smaller lacteal vessels and, ultimately, less weight gain.
Gut microbiome joins the chain
The effect did not stop at gut anatomy. When fructose could not be metabolized normally in small intestine cells, more of it traveled further down the digestive tract, altering the gut microbiome. That shift appeared to affect immune cells in the intestinal wall linked to the growth of lacteal vessels.
In mice with blocked intestinal fructose metabolism, specific gut macrophages decreased, the lacteals stayed smaller and fat absorption remained limited. The researchers then transferred gut microbiome from the genetically modified mice into normal mice, and the recipients also developed smaller lacteals and reduced fat absorption.
The proposed chain runs: fructose metabolism, then microbiome, then intestinal immune cells, then lacteal vessels, then fat absorption, then body weight, an entire metabolic domino effect confined to a few centimeters of gut tissue.
Is this a new obesity drug?
Not yet, and that caveat matters most. The findings rest largely on mouse experiments, and a mechanism working in an animal model does not guarantee the same intervention will be safe, effective or even significant in humans.
What does raise therapeutic interest is KHK itself. If pharmacological inhibition of fructose metabolism could reproduce part of this effect in people, the enzyme could eventually become a new metabolic drug target. Recent preclinical data already point that way: pharmacological inhibition of KHK in mouse models of obesity has been shown to limit absorption of certain dietary fats and boost weight loss when combined with GLP-1 receptor agonists, though this remains experimental research rather than an established human treatment.
Not a reason to eat more fructose
The discovery does not show that eating fructose causes weight loss. It shows close to the opposite: a possible mechanism by which fructose metabolism eases fat absorption and contributes to weight gain, and therefore a potential target that could one day be blocked therapeutically.
It is also important not to lump a sugar-sweetened soft drink together with a whole piece of fruit. The World Health Organization recommends that carbohydrates come mainly from whole grains, vegetables, fruit and legumes, while free sugars, including those added to foods and drinks, should be limited.
Greek public health guidance follows the same line. The National Public Health Organization (EODY) says obesity prevention depends on lasting lifestyle changes: a Mediterranean-style diet, more fruit, vegetables, legumes and whole-grain products, less processed food and less food high in added sugar, water instead of calorie-laden drinks, and regular physical activity.
A small enzyme, a much bigger question
The study does not hand doctors an anti-obesity pill, but it does offer something that in science often comes years before a new drug: a new mechanism. Until now, the fructose debate centered mainly on calories, the liver, fat production and the metabolic effects of eating too much sugar.
Now the microbiome, immune cells and the tiny lymphatic vessels that carry fat out of the gut are part of the picture too. The question is no longer just how much sugar people eat, but what that sugar does inside the gut to change how everything else is absorbed. If the mechanism holds up in humans, KHK could prove to be an interesting therapeutic target for metabolic disease. Until then, the practical advice stays the same: less added and free sugar, less ultra-processed food, and more food in its natural form.
